In the context of SARS-CoV-2 infection, several studies have shown that a robust and timely IFN-I response is associated with milder disease, while delayed or suppressed IFN signaling correlates with severe COVID-19 outcomes [6,7]. The gene discussed is IFNA1; the disease is COVID-19.